Inhibition of Prostate Cancer Cell Colony Formation by the Flavonoid Quercetin Correlates with Modulation of Specific Regulatory Genes

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 1, 2004, Pages 63-69

  Nair, Hari Krishnan ^a   Rao, Kesava V K ^a   Aalinkeel, Ravikumar ^a   Mahajan, Supriya ^a   Chawda, Ram ^a   Schwartz, Stanley A ^a,b,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONOID; NATURAL PRODUCT; QUERCETIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE; CELL STRAIN; CELL STRAIN BG 9; CELL STRAIN LNCAP; CHEMOPROPHYLAXIS; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; NUTRIENT; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL; REGULATOR GENE; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; ONCOGENES; PROSTATIC NEOPLASMS; QUERCETIN; TUMOR STEM CELL ASSAY;

EID: 0347758628     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.1.63-69.2004     Document Type: Article

References (44)

1. Albini, A., Y. Iwamoto, H. K. Kleinman, G. R. Martin, S. A. Aaronson, J. M. Kozlowski, and R. N. McEwan. 1987. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:3239-3245.
2. Burgering, B. M., and P. J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599-602.
3. Elattar, T. M., and A. S. Virji. 2000. The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res. 20:1733-1738.
4. Ember, I., Z. Pusztai, Z. Gyongyi, and I. Kiss. 2000. 1-Nitropyrene induces elevated expression of oncogenes and tumor suppressor genes 24 hours after treatment in CBA/Ca mice. Anticancer Res. 20:1563-1566.
5. Ferry, D. R., A. Smith, J. Malkhandi, D. W. Fyfe, P. G. deTakats, D. Anderson, J. Baker, and D. J. Kerr. 1996. Phase I clinical trial of the flavonoid quercetin: pharmacokinctics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res. 2:659-668.
6. Fidler, I. J., and L. M. Ellis. 1994. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185-188.
7. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27-31.
8. Foster, C. S., P. Cornford, L. Forsyth, M. B. Djamgoz, and Y. Ke. 1999. The cellular and molecular basis of prostate cancer. Br. J. Urol. Int. 83:171-194.
9. Gupta, K., and D. Panda. 2002. Perturbation of microtubule polymerization by quercetin through tubulin binding: a novel mechanism of its antiproliferative activity. Biochemistry 41:13029-13038.
10. Hanahan, D., and J. Folkman. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
11. Horoszewicz, J. S., S. S. Leong, E. Kawinski, J. P. Karr, H. Rosenthal, T. M. Chu, E. A. Mirand, and G. P. Murphy. 1983. LNCaP model of human prostatic carcinoma. Cancer Res. 43:1809-1818.
12. Hunter, T., and J. Pines. 1991. Cyclins and cancer. Cell 66:1071-1074.
13. Jaeschke, A., J. Hartkamp, M. Saitoh, W. Roworth, T. Nobukuni, A. Hodges, J. Sampson, G. Thomas, and R. Lamb. 2002. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J. Cell Biol. 159:217-224.
14. Kandaswami, C., and E. Middleton, Jr. 1994. Free radical scavenging and antioxidant activity of plant flavonoids. Adv. Exp. Med. Biol. 366:351-376.
15. Kaneuchi, M., M. Sasaki, Y. Tanaka, N. Sakuragi, S. Fujimoto, and R. Dahiya. 2003. Quercetin regulates growth of Ishikawa cells through the suppression of EGF and cyclin D1. Int. J. Oncol. 22:159-164.
16. Krol, W., S. Dworniczak, G. Pietsz, Z. P. Czuba, M. Kunicka, M. Kopacz, and D. Nowak. 2002. Synthesis and tomoricidal activity evaluation of new morin and quercetin sulfonic derivatives. Acta Pol. Pharm. 59:77-79.
17. 86rubidium transport in wild-type and ouabain-resistant C3H/10T1/2 mouse fibroblasts. Cancer Res. 40:4581-4588.
18. Landolph, J. R., and C. Heidelberger. 1979. Chemical carcinogens produce mutations to ouabain resistance in transformable C3H/10T1/2 C1 8 mouse fibroblasts. Proc. Natl. Acad. Sci. USA 76:930-934.
19. Lee, L. T., Y. T. Huang, J. J. Hwang, P. P. Lee, F. C. Ke, M. P. Nair, C. Kanadaswam, and M. T. Lee. 2002. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res. 22:1615-1627.
20. Liotta, L. A., and E. C. Kohn. 2001. The microenvironment of the tumour-host interface. Nature 411:375-379.
21. Liotta, L. A., P. S. Steeg, and W. G. Stetler-Stevenson. 1991. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327-336.
22. Liu, A. X., J. R. Testa, T. C. Hamilton, R. Jove, S. V. Nicosia, and J. Q. Cheng. 1998. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells. Cancer Res. 58:2973-2977.
23. Mahajan, S. D., S. A. Schwartz, and M. P. Nair. 2003. Immunological assays for chemokine detection in In-vitro culture of CNS cells. Biol. Proc. Online 5:90-102.
24. Mahmoud, N. N., A. M. Carothers, D. Grunberger, R. T. Bilinski, M. R. Churchill, C. Martucci, H. L. Newmark, and M. M. Bertagnolli. 2000. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogcnesis 21:921-927.
25. Middleton, E., Jr., and C. Kandaswami. 1993. The impact of plant flavonoids on mammalian biology: implication for immunity, inflammation and cancer, p. 619-645. In J. B. Harborne (ed.), The flavonoids: advances in research since 1986. Chapman & Hall, London, United Kingdom.
26. Nair, M. P., C. Kandaswami, S. Mahajan, K. C. Chadha, R. Chawda, H. Nair, N. Kumar, R. E. Nair, and S. A. Schwartz. 2002. The flavonoid, quercetin, differentially regulates Th-1 (IFNgamma) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochim. Biophys. Acta 1593:29-36.
27. Reznikoff, C. A., J. S. Bertram, D. W. Brankow, and C. Heidelberger. 1973. Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res. 33:3239-3249.
28. Robbins, D. H., and S. H. Itzkowitz. 2002. The molecular and genetic basis of colon cancer. Med. Clin. N. Am. 86:1467-1495.
29. Scolnick, D. M., N. H. Chehab, E. S. Stavridi, M. C. Lien, L. Caruso, E. Moran, S. L. Berger, and T. D. Halazonetis. 1997. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res. 57:3693-3696.
30. Shay, J. W. 1997. Telomcrase in human development and cancer. J. Cell. Physiol. 173:266-270.
31. Shay, J. W., O. M. Pereira-Smith, and W. E. Wright. 1991. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196:33-39.
32. 1 phase progression: cycling on cue. Cell 79:551-555.
33. Suzuki, I., I. Hayashi, T. Takaki, D. S. Groveman, and Y. Fujimiya. 2002. Antitumor and anticytopenic effects of aqueous extracts of propolis in combination with chemotherapeutic agents. Cancer Biother. Radiopharm. 17:553-562.
34. Theoharides, T. C., M. Alexandrakis, D. Kempuraj, and M. Lytinas. 2001. Anti-inflammatory actions of flavonoids and structural requirements for new design. Int. J. Immunopathol. Pharmacol. 14:119-127.
35. Tsugawa, K., M. K. Jones, K. Sugimachi, I. J. Sarfeh, and A. S. Tarnawski. 2002. Biological role of phosphatase PTEN in cancer and tissue injury healing. Front. Biosci. 7:245-251.
36. Van Rijn, J., and J. van den Berg. 1997. Flavonoids as enhancers of X-ray-induced cell damage in hepatoma cells. Clin. Cancer Res. 3:1775-1779.
37. Wang, H. K. 2000. The therapeutic potential of flavonoids. Expert Opin. Investig. Drugs 9:2103-2119.
38. Webber, M. M., D. Bello, and S. Quader. 1997. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 2. Tumorigenic cell lines. Prostate 30:58-64.
39. Wei, B. L., C. M. Lu, L. T. Tsao, J. P. Wang, and C. N. Lin. 2001. In vitro anti-inflammatory effects of quercetin 3-O-methyl ether and other constituents from Rhamnus species. Planta Med. 67:745-747.
40. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
41. 1 arrest followed by cell death. Cancer Res. 59:5808-5814.
42. Wright, W. E., O. M. Pereira-Smith, and J. W. Shay. 1989. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol. Cell. Biol. 9:3088-3092.
43. Young, J. F., S. E. Nielsen, J. Haraldsdottir, B. Daneshvar, S. T. Lauridsen, P. Knuthsen, A. Crozier, B. Sandstrom, and L. O. Dragsted. 1999. Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. Am. J. Clin. Nutr. 69:87-94.
44. Zhang, X, D., X. Y, Zhang, C, P. Gray, T. Nguyen, and P, Hersey. 2001. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Cancer Res. 61:7339-7348.